OR WAIT null SECS
© 2021 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
September 02, 2021
Tecentriq and Keytruda may also be eventually approved as adjuvant therapies.
September 01, 2021
Developers of the drug express disappointment but plan to seek meetings with regulators in hopes of reviving the application.
August 13, 2021
The confirmatory trial of one of the approved drugs, Pepaxto, was halted when data suggested it was associated with a higher mortality rate.
August 12, 2021
At this time, two of three conferences have been reverted to a in-person and virtual format. This includes The American Urological Association (AUA) 2021 Annual Meeting and the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting.